Summary: At present, neither the diagnostic efficiency, the analytic reliability, nor the practicability of clinical chemical tests for estimation of the degree and/or activity of the fibrotic transformation of the chronically injured liver are satisfactory. Among the various parameters proposed, the determination of the activity of monoamine oxidase (monoaniine: O 2 oxidoreductase, EC 1.4.3.4) in serum seems to be advantageous. To facilitate its routine use we studied some important practical aspects of the new colorimetric assay for the activity of monoamine oxidase in serum. The reaction procedes linearly with time for at least two hours and with enzyme concentrations up to 6 kU/1.
Unter den 26 getesteten Kontrollseren enthalten nur wenige Monoaminoxidase-Aktivität, die quantitativ (d.h. vergleichbare katalytische Konzentration) und qualitativ (d. h. vergleichbare Sensitivität gegenüber /3-Aminopropionitril und ähnliches Aktivitätsverhältnis in Tris-/Phosphat-Puffer) der in menschlichen Seren vorhandenen entspricht. Mithin sind nur wenige der kommerziell erhältlichen Kontrollseren für die Präzisionskpntrolle dieser Bestimmung geeignet.
Introduction
A common sequel of diverse forms of chronic hepatocellular damage is the fibrotic change of the liver parenchyma. The process, which is characterized by strong accumulation of complex connective tissue proteins such as various types of collagens (1, 2) and proteoglycans (3, 4) , is believed to involve stimulated synthesis rather than reduced breakdown of the intercellular macromolecules (5) (6) (7) (8) . Despite its great clinical significance, the early diagnosis and therapeutic monitoring of hepatic fibroproliferation by biochemical means is presently hindered by a limited supply of reliable and practicable clinical-chemical parameters (9) (10) (11) . Of these, the determination of the activity of monoamine oxidase (monoamine: 0 2 oxidoreductase, EC 1.4.3.4) in serum has been proposed as a useful, supplementary diagnostic procedure for organ fibrosis, in particular for active hepatic fibrosis (12) (13) (14) . Reported data (15, 16) suggest the superiority of this enzyme to other currently available biochemical markers of liver fibrosis, but direct and quantitative comparisons have not yet been published. In order to make the determination of the activity of monoamine oxidase in human serum suitable for standardized routine clinical use and interlaboratory comparisons, it seemed necessary to us to study some important properties of the enzyme and of the recently developed, simplified, colorimetric assay system (15) .
Materials and Methods
Materials l-[(4-aminomethyl-phenyl)azo]-2-naphthol hydrochloride was purchased from Wako Pure Chemical Industries, Osaka, Japan; 0-aminopropionitrile fumarate (lot 108 C-0164) was from Sigma Chemical Comp., München, FRG; phosphate buffer solution (0.067 mol/1, pH 7.3 (20 °C), lot 203209 A) and the clearing agent for turbid sera (Frigen) were from Behring Institute, Marburg/Lahn, FRG; Sure-Sep II serum-plasma seperator was from General Diagnostics, Morris Plains, USA; the sources of control sera are listed in table 3. All other reagents were of analytical grade.
Methods
Serum was prepared by centrifugation of venous blood which had been allowed to clot for 1 hour at room temperature, using the Sure-Sep II serum-plasma separator. Platelet-free plasma was obtained by anticoagulation of 3 ml of blood in heparin-(Sarstedt, N? 358) or ethylenediaminetetraacetate (EDTA)-(Sarstedt, N? 328) containing test tubes and subsequent centrifugation, using the Sure-Sep II serum-plasma separator.
In principle the activity of monoamine oxidase in sera was determined according to the method of Ono et al. (15) . 0.5 ml serum were incubated for one hour at 37 °C with 1.0 ml of l-[(4-aminomethyl-phenyl)azo]-2-naphthol hydrochloride (0.5 mmoi/1) and an equal volume of 0.1 mol/1 Tris-HCl buffer, pH 7.2 (20 °C). The reaction was terminated by the addition of 0.1 ml perchloric acid, and l-[(4-formylphenyl)azo]-2-naphthol formed during incubation was extracted with cyclohexane and quantitated by measuring its absorbance at 500 nm against cyclohexane. The calculation of the enzyme activity was based on the reported molar absorptivity of the reaction product (15) . Modifications of this general procedure are described in the legends of the appropriate figures and tables.
General determinations
Hemoglobin was determined according to clinical-chemical standard procedures (17) , total bilirubin (18) arid triglycerides (19) were measured in a DuPont Automatic Clinical Analyzer and GEMSAEC fast analyzer, respectively.
Results
The time-course of the monoamine oxidase assay in human serum and two quality control sera is shown in figure 1. The reaction proceeds linearly with time for at least 2 hours, but marked differences were noted in the activities of the enzyme depending on the buffer system used. Monoamine oxidase in Seronorm ( fig. la) The serum containing the highest activity of monoamine oxidase (Seronorm) was used to study the effect of enzyme concentration on the reaction rates at different temperatures ( fig. 2 ). The enzyme activity increased proportionally at least up to 6 kU/1 which is about 15 times above the activity in normal human serum. The activity of the enzyme in Tris-HCl buffer at 37 °C was about 60% of that in phosphate buffer at 30 °C and increased linearly with serum volume only up to 1.7 kU/1. At an incubation temperature of 46 °C a sigmoidal activity curve reaching a plateau at about 10 kU/1 was observed. The temperature correction factors and temperature-dependent tris/phosphate activity ratios of monoamine oxidase in human serum and Seronorm are summarized in table 1. In agreement with the information given in figure 1 the data show clearly significant differences between the enzymes in both sera, in particular a strong and differential effect of incubation temperature on the enzyme activity in Tris-HCl and phosphate buffer, respectively. The adverse effects of the lathyrogenic compound j3-aniinopropioriitrile on monoamine oxidase activity in human serum and Seronorm are illustrated by figure 3. In human serum 50% inhibition is reached at 0.003 mol/l, complete inhibition at 0.150 mol/l. In the control serum, however, the activity was found to be greatly stimulated by the drug, the strongest increase (nearly 2.5 fold) was observed at 0.080 mol/l j3-aminopropionitrile. The results of intra-and inter-assay precision analyses are shown in table 2. The accuracy of the test is difficult to assess at present since no adequate control sera are ob- tainable. Applying the above mentioned criteria (tris/ phosphate activity ratio, effect of /J-aminopropionitrile) a series of commercially available quality control sera was analysed for monoamine oxidase to select the most Tab. 1. The effect of temperature on the buffer-dependent activity of monoamine oxidase in a quality control serum (Seronorm) and normal human serum. The samples were incubated for 1 hour at 20 °C, 30 °C and 37 °C either in the presence of a Tris-HCl (pH 7.2) or phosphate buffer (pH 7.3) as described in fig. 1 . The conversion factors and activity ratios were calculated from 4 independent measurements. suitable ones for routine quality control (table 3) . Among the 26 sera tested 11 contained monoamine oxidase quantitatively and qualitatively similar (albeit not identical) to that in sera of normal and liver-cirrhotic human subjects (table 3) . The remaining sera had enzyme activities definitely different from the human type and, hence, are not favourable to precision control analyses of monoamine oxidase assay in normal and pathologic human sera. It should be noted, that among the mixed type sera originating mainly from animal and less from human sources, Wellcomtrol 1,3, and 2 contained the highest activities, but the enzyme in the last mentioned serum was not influenced by the lathyrogenic drug.
The conditions of storage of the sample are of great importance for a correct analysis ( fig. 4) . If the serum is kept at room temperature the activity of monoamine oxidase declines very rapidly, during the first 48 h by 30%/day. Best preservation of catalytic function in sera is achieved either by deep-freezing, or by storage at +4°C (fig.4 ).
Hemolysis and hyperbilirubinemia do not interfere significantly with the assay of monoamine oxidase activity in human serum (tab. 4). In hyperlipemic sera a significant increase in the activity was noted which can be avoided by delipid tion of the serum with Frigen based agents prior to use (table 4) . In no case, there was a need to perform blank incubations, i.e. serum added after termination of the reaction. The activities of monoamine oxidase in serum, ethylenediaminetetraacetate (EDTA)-andheparin-anticoagulated, platelet-free plasma of 8 healthy persons were 374 ± 99 U/l, 377 ± 93 U/l and 390 ± 100 U/l, respectively. Thus, serum and plasma seem to be interchangeable for the determination of monoamine oxidase.
The activities of monoamine oxidase in the sera of 178 healthy persons are listed iri table 5. They do not show significant sex-related differences. In the age groups (18 to 55 years) tested no effect of age on enzyme activity was noted (data not shown).
Increases iri the concentration of Cu 2+ and Mg 
Discussion
Human blood serum contains a'soluble monoamine oxidase that deaminates a variety of monoamines including n ί™**" benzylamine, tyramine, tryptamine, dopamine and phenylethylamine (21, 22) . Neither the physiological role nor the origin of the circulating form of monoamine oxidase are known. In its substrate specifity it resembles the type B (23-25) mitochondria! outer membrane monoamine oxidase, but the inhibition by lathyrogens (26, 27) , such as j3-aminopropionitrile, and electrophoretic mobility clearly indicate marked differences between these two enzymes (12, 28) . As a further criterion we showed that the serum enzyme is insensitive to Cu 24 ", whereas the liver mitochondrial enzyme was reported to be strongly inactivated (29) . Previous studies have demonstrated elevated enzyme activities under several pathological conditions, especially iri progressive hepatic fibrosis (12) (13) (14) (15) (16) (30) (31) (32) . The latter observation established the diagnostic significance of the enzyme and suggested that it might catalyze the initial step of collagen cross-linking in the liver (12, 31, 32) . However, purified amine oxidase does not utilize collagen substrates (33) and is antigenically different from liver lysyl oxidase (34) , which also increases in the serum of liver-fibrotic rats (35) . Thus, the role of serum monoamine oxidase in hepatic connective tissue metabolism remains obscure. Obviously serum monoamine oxidase is composed of multiple, biologically undefined forms (15) of which the quantitative relation might change in certain pathological states (32) . Modifications of the assay conditions can therefore selectively affect the activity pattern of the isoenzymes of monoamine oxidase in health and disease. We have shown that there is an increase in the activity of the human serum enzyme if the phosphate buffer originally used by Me Ewen & Cohen (21) is replaced by Tris-HQ buffer, and, furthermore, that the temperature correction factors are different for the two buffer systems. According to our results, sera from cirrhotic patients contain monoamine oxidase that is qualitatively similar to that in normal serum, but differences in the isoenzyme composition have been described (32, 36, 37) . It should be emphasized that quality control of the assay Tab. 4. Interferences of hemolysis, hyperlipemia, and bilirubinemia with the determination of monoamine oxidase activity in human serum. conditions is comlicated by the fact that only few commercially available control sera contain monoamine oxidase approximating to the human serum type. The variable degrees of the inhibition (in Seronorm even strong activation!) by /J-aminopropionitrile suggest the presence of variable amounts of type B tissue monoamine oxidase in the sera, which might also explain their different Tris/ phosphate activity ratios.
Although the within-run precision is satisfactory, the disadvantages (large sample volumes, time-consuming and manual procedure, relative insensitivily) of even the improved colorimetric mothod (15) hinder its frequent application in the routine diagnosis of hepatic fibroproliferation. To overcome these drawbacks we are currently developing a sensitive arid rapid kinetic procedure for the assay of monoamine oxidase activity in serum which can be fully mechanized.
